Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

10.84 -1.90 (-14.91%)

Delayed Quote Updated: 2:03 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Carnival, Ginkgo Bioworks And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

November 16, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Ginkgo Bioworks Stock Is Down After Hours: What's Happening? ↗

November 15, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering.

Via Benzinga

What's Going On With Ginkgo Bioworks Stock After Hours? ↗

November 14, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company

Via Benzinga

3 Unstoppable Stocks That Could Double in 5 Years ↗

October 29, 2022

The opportunities for these innovators are tremendous.

Via The Motley Fool

Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher? ↗

October 20, 2022

It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus.

Via InvestorPlace

Ignore the Hype! These Are 7 of the Worst Stocks to Own Now ↗

October 20, 2022

Looking for great bear-market bargains? Separate the wheat from the chaff and avoid these seven stocks to sell.

Via InvestorPlace

Co-founders Keep Buying Ginkgo Bioworks (DNA) Stock ↗

October 06, 2022

Three co-founders of Ginkgo Bioworks, including CEO Jason Kelly, have filed updated forms detailing their increased stakes in DNA stock.

Via InvestorPlace

5 Top Stocks Cathie Wood Is Buying This Week ↗

October 17, 2022

In an open letter to the Fed, Cathie Wood notes that deflationary fears could come to fruition, replacing inflationary fears.

Via InvestorPlace

Morgan Stanley, First Republic Bank And Other Big Losers From Friday ↗

October 17, 2022

U.S. stocks closed lower on Friday, with the Dow Jones dropping over 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

10 Top Stock Market Predictions for 2023 ↗

October 12, 2022

The top stock market predictions for 2023 show that the new year will be one in which hypergrowth stocks dominate. Don't miss out.

Via InvestorPlace

DFLI Stock Alert: What to Know as Battery Maker Dragonfly Energy Starts Trading ↗

October 11, 2022

Dragonfly Energy (DFLI) stock is catching the interest of traders on Tuesday after the company's shares went public yesterday.

Via InvestorPlace

Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing ↗

October 11, 2022

Via Benzinga

What Is Going on With Vox Royalty (VOXR) Stock Today? ↗

October 11, 2022

Vox Royalty (VOXR) stock is seeing incredibly volatile trading on Tuesday after the company uplisted shares to the Nasdaq Exchange.

Via InvestorPlace

Why Is Laser Photonics (LASE) Stock Up 55% Today? ↗

October 11, 2022

Laser Photonics (LASE) stock is taking off on Tuesday after the company revealed a new order from the U.S. Navy to be filled this month.

Via InvestorPlace

What Is Going on With Ginkgo Bioworks (DNA) Stock Today? ↗

October 11, 2022

Ginkgo's planned collab with a pharma giant should spark a rally in DNA stock - but then, sometimes logic doesn't prevail on Wall Street.

Via InvestorPlace

5 Top Stocks Cathie Wood Is Buying This Week ↗

October 07, 2022

Ark Invest is making headlines again. Cathie Wood continues to purchase more shares of companies like Tesla despite headwinds.

Via InvestorPlace

2 Growth Stocks That Could Rocket 80% to 102% Higher, According to Wall Street ↗

October 07, 2022

Analysts expect these stocks to rise more than 100% once the rest of the market sees their underlying businesses in the same light.

Via The Motley Fool

Analyzing Ginkgo Bioworks Holdings's Short Interest ↗

October 06, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 8.12% since its last report. The company recently reported that it has 187.61 million shares sold short, which is 25.02% of all...

Via Benzinga

Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock ↗

October 06, 2022

The famed investor who focuses on disruptive technologies has been buying DNA stock hand-over-fist in recent days.

Via InvestorPlace

Why Is Ginkgo Bioworks Stock Up Today? ↗

October 04, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Tuesday after the company announced the acquisitions of Altar and Circularis. Terms of the deals were not disclosed.

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

September 30, 2022

There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public.

Via InvestorPlace

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Cramer Warns Investor To Avoid This Entire Industry: 'I Do Not Want You To Touch Any Of These Stocks' ↗

September 28, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Everbridge Inc (NASDAQ: EVBG) as it does not make money.

Via Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

Peering Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

September 20, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 24.11% since its last report. The company recently reported that it has 179.06 million shares sold short...

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

September 09, 2022

Cathie Wood's Ark Invest had an active week of buying shares in companies like DKNG and TDOC. Investors are intrigued by Cathie Wood stocks.

Via InvestorPlace

Don’t Jump Into the Deepening Financial Hole with Ginkgo Bioworks ↗

August 29, 2022

You don't have to mimic Wood's trades, as DNA stock could continue its downward trajectory due to Ginkgo Bioworks' imperfect financials.

Via InvestorPlace

5 Cathie Wood Stocks Signaling “The Bear Market Is Over” ↗

August 22, 2022

These top Cathie Wood stocks are signalling that the bear market is over. For savvy investors, that presents a chance to profit.

Via InvestorPlace

Wayfair, Bed Bath & Beyond And Other Big Losers From Friday ↗

August 22, 2022

U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Resources